Technologies

The invention relates to tagatose which has improvement effect on inflammation and fatty liver, and the tagatose is an effective component of the product, belongs to a food and drug additive and a food and drug composition utilizing the technology. Tagatose can effectively inhibit the phagocytosis of apoA-I macrophage LDL, has anti-inflammatory activity, belongs to zebrafish type, can reduce the increase of serum neutral fat due to high cholesterol, and reduce fatty liver. Therefore, the invention can effectively reduce fatty liver and inflammation, and is widely used as food and medicine additive in related aspects.